N.E.E. 1 Drug Patent Profile
✉ Email this page to a colleague
When do N.e.e. 1 patents expire, and when can generic versions of N.e.e. 1 launch?
N.e.e. 1 is a drug marketed by LPI and is included in two NDAs.
The generic ingredient in N.E.E. 1 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for N.E.E. 1?
- What are the global sales for N.E.E. 1?
- What is Average Wholesale Price for N.E.E. 1?
Summary for N.E.E. 1
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | N.E.E. 1 at DailyMed |
US Patents and Regulatory Information for N.E.E. 1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lpi | N.E.E. 1/35 21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071541-001 | Dec 14, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lpi | N.E.E. 1/35 28 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 071542-001 | Dec 14, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
